Pharmacists in Allegan, Michigan


13 Pharmacists found in Allegan
female pharmacist

Mrs. Andrea Nicole Menhart, PHARMD


Pharmacist
115 Locust St, Allegan, MI 49010
269-673-4188     269-673-6773

male pharmacist

Dr. Andrew Joseph Swailes, PHARMD


Pharmacist
560 Jenner Dr, Allegan, MI 49010
269-673-2181    

female pharmacist

Carolyn Harris


Pharmacist
100 Monroe St, Allegan, MI 49010
269-673-6749    



male pharmacist

Dr. Christopher Douglas Harris, PHARM.D.


Pharmacist
100 Monroe St, Suite B, Allegan, MI 49010
269-673-6749     269-673-9491

male pharmacist

Conrad William Beeler, RPH


Pharmacist
560 Jenner Dr, Allegan, MI 49010
269-673-2181    

female pharmacist

Jill Marie Polidan, PHARMD


Pharmacist
100 Monroe St Ste B, Allegan, MI 49010
269-673-6749    

male pharmacist

Joel Light


Pharmacist
100 Monroe St Ste B, Allegan, MI 49010
269-673-6749     269-673-9491

female pharmacist

Mrs. Kelly Sue Herriman


Pharmacist
100 Monroe St, Allegan, MI 49010
269-673-6749    

male pharmacist

Mr. Manoj Sebastian, RPH


Pharmacist
560 Jenner Dr, Allegan, MI 49010
269-673-2181    

male pharmacist

Dr. Mohamed A Beydoun, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
551 Linn St Ste 120, Allegan, MI 49010
269-673-4700    

male pharmacist

Ryan David Moore, R.PH., M.B.A.


Pharmacist
100 Monroe St, Allegan, MI 49010
269-673-6749     269-673-9491

male pharmacist

Mr. Scott Christopher Krzemen, PHARM. D.


Pharmacist
555 Linn St, Allegan, MI 49010
269-686-4120    

female pharmacist

Vicki Lynn Hodge, RPH


Pharmacist
115 Locust St, Allegan, MI 49010
269-673-4188    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.